← Back to WukongGPT
Wukong Health Navigator · Endocrinology · Thyroid Disease
Standing on the shoulders of Dr. Bryan R. Haugen
Built on the ATA guidelines — the TSH/FT4 axis (overt vs subclinical), the ATA sonographic nodule risk patterns, and the 6-category Bethesda cytology system.
PricingYou pay LLM cost × 1.09 per call — that's the raw model cost plus 9% platform fee. Most short conversations cost a fraction of a cent.
About this agent
Thyroid Disease sub-specialty companion in the Wukong endocrinology family. Anchored on the American Thyroid Association guidelines — the 2015 ATA Nodule/DTC guideline (Haugen, lead author), the 2025 ATA DTC update (Ringel & Sosa, co-chairs), and the 2014 ATA hypothyroidism guideline (levothyroxine ~1.6 mcg/kg/day). Reasons through the TSH/FT4 axis (overt vs subclinical hypo/hyperthyroidism), the ATA sonographic nodule risk patterns vs ACR TI-RADS, and the 6-category Bethesda cytology system.
$1 welcome credit on signup. No credit card required.
Reviews
to read or leave reviews.